4-nitroquinoline-1-oxide has been researched along with piperidines in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, S; Hatano, M; Koshiura, R; Miyamoto, K | 1 |
Fronza, G; Lanza, A; Pedrini, AM; Rodolfo, C; Tornaletti, S | 1 |
Doçi, CL; Hasina, R; Lingen, MW; Mankame, TP; Wroblewski, K; Zhou, G | 1 |
3 other study(ies) available for 4-nitroquinoline-1-oxide and piperidines
Article | Year |
---|---|
Suggestive evidence for relationship between sensitivity and repair capability in rat ascites hepatoma cells treated with the antitumor agent, 1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinoma, Hepatocellular; Cell Line; DNA Repair; DNA, Bacterial; Escherichia coli; Female; Liver Neoplasms; Mutation; Neoplasms, Experimental; Nitrogen Mustard Compounds; Piperidines; Rats | 1977 |
The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions.
Topics: 4-Nitroquinoline-1-oxide; Base Sequence; DNA; DNA Damage; DNA, Superhelical; Molecular Sequence Data; Nucleic Acid Conformation; Piperidines; Polydeoxyribonucleotides; Structure-Activity Relationship | 1994 |
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Immunohistochemistry; Mice; Mice, Inbred CBA; Mouth Neoplasms; Neovascularization, Pathologic; Piperidines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor | 2010 |